Clinical & Experimental Metastasis

Springer Science+Business Media

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Clinical & Experimental Metastasis is a journal published by Springer Science+Business Media in Netherlands. It is listed in MEDLINE according to the sources read. Declared publication charge: 4,290 EUR. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Springer Science+Business Media
ISSN
0262-0898 · 1573-7276
Country
Netherlands
Access
Not open access / not declared
Declared publication charge
4,290 EUR
Declared peer-review model
peer_review

Index listings

  • MEDLINE · 1983-01-01
Indexing
MEDLINE
APC
4,290 EUR
Declared review time (DOAJ)
—
Actual review time (measured)
118 days received→accepted — computed from PubMed (n=96)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

2783

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

126

i10-index

1922

From OpenAlex open data (CC0).

Editorial & policy6
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
96%
ORCID iDs in current deposits
26%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
Identity & continuity3
Source type
journal
NLM unique ID (PubMed)
8409970
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Cancer Cells and Metastasis
  • Cancer Cells and Metastasis
  • Cell Adhesion Molecules Research
  • Cell Adhesion Molecules Research
  • Protease and Inhibitor Mechanisms
  • Protease and Inhibitor Mechanisms
  • Peptidase Inhibition and Analysis
  • Peptidase Inhibition and Analysis
Show all subjects (50)
  • Cancer Research and Treatments
  • Cancer Research and Treatments
  • Cancer Genomics and Diagnostics
  • Cancer Genomics and Diagnostics
  • Immunotherapy and Immune Responses
  • Immunotherapy and Immune Responses
  • Cancer, Hypoxia, and Metabolism
  • Cancer, Hypoxia, and Metabolism
  • Angiogenesis and VEGF in Cancer
  • Angiogenesis and VEGF in Cancer
  • Bone health and treatments
  • Bone health and treatments
  • Brain Metastases and Treatment
  • Glycosylation and Glycoproteins Research
  • Glycosylation and Glycoproteins Research
  • Brain Metastases and Treatment
  • Cellular Mechanics and Interactions
  • Cellular Mechanics and Interactions
  • Radiopharmaceutical Chemistry and Applications
  • Cancer Diagnosis and Treatment
  • Cancer Diagnosis and Treatment
  • Radiopharmaceutical Chemistry and Applications
  • Prostate Cancer Treatment and Research
  • Prostate Cancer Treatment and Research
  • Monoclonal and Polyclonal Antibodies Research
  • Monoclonal and Polyclonal Antibodies Research
  • Glioma Diagnosis and Treatment
  • Glioma Diagnosis and Treatment
  • Proteoglycans and glycosaminoglycans research
  • Proteoglycans and glycosaminoglycans research
  • Lung Cancer Treatments and Mutations
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Lung Cancer Treatments and Mutations
  • Sarcoma Diagnosis and Treatment
  • Virus-based gene therapy research
  • Virus-based gene therapy research
  • Sarcoma Diagnosis and Treatment
  • Cancer Immunotherapy and Biomarkers
  • Lung Cancer Research Studies
  • Cancer Immunotherapy and Biomarkers
  • Lung Cancer Research Studies

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: